Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11571065rdf:typepubmed:Citationlld:pubmed
pubmed-article:11571065lifeskim:mentionsumls-concept:C0013227lld:lifeskim
pubmed-article:11571065lifeskim:mentionsumls-concept:C0025663lld:lifeskim
pubmed-article:11571065lifeskim:mentionsumls-concept:C0033105lld:lifeskim
pubmed-article:11571065lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:11571065lifeskim:mentionsumls-concept:C0018223lld:lifeskim
pubmed-article:11571065lifeskim:mentionsumls-concept:C1546940lld:lifeskim
pubmed-article:11571065pubmed:issue10lld:pubmed
pubmed-article:11571065pubmed:dateCreated2001-9-25lld:pubmed
pubmed-article:11571065pubmed:abstractTextThe European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has produced methodological guidelines for national drug prevalence estimation. This paper pilots the methods to estimate prevalence for Great Britain and provides a commentary on the methods and resulting estimates.lld:pubmed
pubmed-article:11571065pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11571065pubmed:languageenglld:pubmed
pubmed-article:11571065pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11571065pubmed:citationSubsetIMlld:pubmed
pubmed-article:11571065pubmed:statusMEDLINElld:pubmed
pubmed-article:11571065pubmed:monthOctlld:pubmed
pubmed-article:11571065pubmed:issn0965-2140lld:pubmed
pubmed-article:11571065pubmed:authorpubmed-author:MarianiFFlld:pubmed
pubmed-article:11571065pubmed:authorpubmed-author:KrausLLlld:pubmed
pubmed-article:11571065pubmed:authorpubmed-author:FrischerMMlld:pubmed
pubmed-article:11571065pubmed:authorpubmed-author:HickmanMMlld:pubmed
pubmed-article:11571065pubmed:authorpubmed-author:WiessingLLlld:pubmed
pubmed-article:11571065pubmed:issnTypePrintlld:pubmed
pubmed-article:11571065pubmed:volume96lld:pubmed
pubmed-article:11571065pubmed:ownerNLMlld:pubmed
pubmed-article:11571065pubmed:authorsCompleteYlld:pubmed
pubmed-article:11571065pubmed:pagination1465-76lld:pubmed
pubmed-article:11571065pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11571065pubmed:meshHeadingpubmed-meshheading:11571065...lld:pubmed
pubmed-article:11571065pubmed:meshHeadingpubmed-meshheading:11571065...lld:pubmed
pubmed-article:11571065pubmed:meshHeadingpubmed-meshheading:11571065...lld:pubmed
pubmed-article:11571065pubmed:meshHeadingpubmed-meshheading:11571065...lld:pubmed
pubmed-article:11571065pubmed:meshHeadingpubmed-meshheading:11571065...lld:pubmed
pubmed-article:11571065pubmed:meshHeadingpubmed-meshheading:11571065...lld:pubmed
pubmed-article:11571065pubmed:meshHeadingpubmed-meshheading:11571065...lld:pubmed
pubmed-article:11571065pubmed:year2001lld:pubmed
pubmed-article:11571065pubmed:articleTitleA comparison of different methods for estimating the prevalence of problematic drug misuse in Great Britain.lld:pubmed
pubmed-article:11571065pubmed:affiliationDepartment of Medicines Management, Primary Care Research Centre, Keele University, Staffordshire, UK. m.fischer@keele.ac.uklld:pubmed
pubmed-article:11571065pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11571065pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11571065lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11571065lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11571065lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11571065lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11571065lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11571065lld:pubmed